Ayala Pharmaceuticals Inc (ADXS)

[huskercatman123]

Thanks for sharing; I was not aware of this:

“The assessment of the TNFa and IFN-? response based on data from eight of the anticipated nine patients to be enrolled in stage 1 confirmed that the clinical study has already met the target for the overall rate of vaccine-induced T-cell response, paving the way for us to progress to stage 2,” said the study’s lead investigator Andrew G. Sikora, MD, PhD, of the Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery at Baylor College of Medicine. “


https://ir.advaxis.com/press-release/clinical-data-updates/advaxis-announces-phase-2-head-and-neck-cancer-study-axal